SCHEMBL19785384

SCHEMBL19785384

Clc1cc(-c2ccccc2)ccc1-c1ccc(-c2ccccc2)cc1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.61
CYP1A2 P05177 1/20 0.52
CSNK2A1 P68400 2/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
MEN1 O00255 1/20 0.48
APAF1 O14727 1/20 0.48
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.48
THRB P10828 1/20 0.48
XBP1 P17861 1/20 0.48
PTBP1 P26599 1/20 0.48
HTT P42858 1/20 0.48
GALK1 P51570 1/20 0.48
BLM P54132 1/20 0.48
SMAD3 P84022 1/20 0.48
KMT2A Q03164 1/20 0.48
ATM Q13315 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16688110 0.93 ESR2 (0.59) ESR2CYP1A2CSNK2A1NPC1RAB9A
SCHEMBL6436155 0.93 ESR2 (0.59) ESR2CYP1A2CSNK2A1NPC1RAB9A
SCHEMBL24781142 0.89 ESR2 (0.55) ESR2CYP1A2CSNK2A1NPC1RAB9A
SCHEMBL24406604 0.86 MAPK1 (0.52) ESR2CYP1A2CSNK2A1NPC1RAB9A
SCHEMBL23446197 0.84 MAPK1 (0.50) ESR2CYP1A2CSNK2A1NPC1RAB9A
SCHEMBL29493845 0.82 AHR (0.74) ESR2CYP1A2MEN1LMNAKMT2A
SCHEMBL1443418 0.82 AHR (0.74) ESR2CYP1A2MEN1LMNAKMT2A
SCHEMBL7465630 0.82 ESR2 (0.48) ESR2CYP1A2CSNK2A1NPC1RAB9A
SCHEMBL29211652 0.82 ESR2 (0.48) ESR2CYP1A2CSNK2A1NPC1RAB9A
SCHEMBL27850823 0.82 ESR2 (0.48) ESR2CYP1A2CSNK2A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10246415-B2 Process for preparing carbazoles DOW GLOBAL TECHNOLOGIES LLC (US) 2019-04-02 US disclosed
WO-2018013067-A1 PROCESS FOR PREPARING CARBAZOLES DOW GLOBAL TECHNOLOGIES LLC (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10246415-B2 Process for preparing carbazoles DCLK2, DCLK1, PDCD2L ESR2 3209/4885CYP1A2 255/4885CSNK2A1 750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.